Literature DB >> 20012513

Primary cutaneous diffuse large B cell lymphoma relapsed solely as a huge lung tumor mimicking a primary pulmonary lymphoma.

Yu-Feng Chen1, Yu-Ching Li, Li-Mien Chen, Chane-Chou Tu, Chen-Chu Chang, Szu-Yin Kuo, Shu-Hui Lin, Shih-Sung Chuang.   

Abstract

Primary cutaneous large B cell lymphoma, leg type (PCLBCL-leg) has recently been identified and recognized as a specific entity. Patients with PCLBCL-leg have a higher relapse rate and a poorer prognosis than the other types of primary cutaneous B cell lymphomas, and disease relapse is confined to the skin in the majority of cases with rare exclusive extracutaneous progression. The late occurrence of lymphoma in patients with a prior history of lymphoma may represent a relapse/progression or a distinct tumor unrelated to the original one. The distinction is of important clinical and therapeutic implications. Here, we report the case of a 90-year-old lady with a history of PCLBCL-leg in complete remission after radiotherapy that developed a huge, solitary pulmonary lymphoma without lymphadenopathy 14 months later. The latter was initially considered as stage IE primary pulmonary lymphoma and was treated with combination chemotherapy resulting in complete remission. Retrospective pathologic review and B cell clonality study revealed that the pulmonary tumor was a diffuse large B cell lymphoma of the same clonal origin as the PCLBCL-leg. This case is unique in the exclusive pulmonary relapse and illustrates the importance of expert pathological review and molecular study in the management of lymphoma patients with unusual clinical features.

Entities:  

Mesh:

Year:  2009        PMID: 20012513     DOI: 10.1007/s12185-009-0455-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

1.  Primary cerebral diffuse large B-cell lymphoma relapsed solely in the skin with the same clonal origin.

Authors:  Shih-Sung Chuang; Hongxiang Liu; Yuanxue Huang; Chung-Ching Chio; Li-Ching Lin
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-01

Review 2.  Primary cutaneous B-cell lymphoma: classification and treatment.

Authors:  Rein Willemze
Journal:  Curr Opin Oncol       Date:  2006-09       Impact factor: 3.645

3.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

4.  Clinicopathologic analysis of cutaneous lymphoma in taiwan: a high frequency of extranodal natural killer/t-cell lymphoma, nasal type, with an extremely poor prognosis.

Authors:  Jia-Bin Liao; Shih-Sung Chuang; Hsiu-Chiung Chen; Hui-Hwa Tseng; Jyh-Seng Wang; Pin-Pen Hsieh
Journal:  Arch Pathol Lab Med       Date:  2010-07       Impact factor: 5.534

5.  Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.

Authors:  F Grange; M W Bekkenk; J Wechsler; C J Meijer; L Cerroni; M Bernengo; J Bosq; G Hedelin; R Fink Puches; W A van Vloten; P Joly; M Bagot; R Willemze
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

Review 6.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

7.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

8.  Detecting clonal rearrangement in non-Hodgkin's lymphomas in Taiwan by polymerase chain reaction.

Authors:  Shih-Sung Chuang; Ching-Nan Lin; Fan-Ching Shen; Pei-Ju Liao; Yung-Liang Liao; Julia Hueimei Chang; Yi-Chang Tsai; Chi-Yi Cho; Wenya Huang
Journal:  Leuk Lymphoma       Date:  2003-01

9.  Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin's lymphoma: the single-institute experience in Taiwan.

Authors:  Yu-Hui Hu; Liang-Tsai Hsiao; Ching-Fen Yang; Tzeon-Jye Chiou; Jin-Hwang Liu; Jyh-Pyng Gau; Chueh-Chuan Yen; Teh-Ying Chou; Wen-Hu Hsu; Po-Min Chen; Cheng-Hwai Tzeng
Journal:  Ann Hematol       Date:  2009-01-13       Impact factor: 3.673

10.  Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis.

Authors:  Massimo Libra; Valli De Re; Daniela Gasparotto; Annunziata Gloghini; Alessandra Marzotto; Isabella Milan; Umberto Tirelli; Franca Stivala; Antonino Carbone; Mauro Boiocchi
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.